Abstract： Objective： To observe the clinical efficacy of Jingui Shenqi Pills combined with Budesonide Formoterol Powder Inhalation for bronchial asthma with kidney yang deficiency type. Methods ： A total of 80 cases of patients with bronchial asthma with kidney yang deficiency type admitted to Lishui People's Hospital from June 2021 to February 2023 were selected and divided into the treatment group and the control group according to the random number table method，with 40 cases in each group．The control group was treated with Budesonide Formoterol Powder Inhalation， and the treatment group was given Jingui Shenqi Pills in addition to the control group's treatment． The clinical efficacy， adverse reactions， traditional Chinese medicine syndrome scores， lung function indicators [peak expiratory flow （PEF），forced expiratory volume in the first second （FEV1），FEV1/forced vital capacity （FVC）]，and the scores of Adult Asthma Quality of Life Questionnaire （AQLQ） were compared between the two groups．Results： The total effective rate was 92.50% （37/40） in the treatment group and 75.00% （30/40） in the control group， the difference being significant （P＜0.05）. After treatment，traditional Chinese medicine syndrome scores and total scores for both primary and secondary symptoms in the two groups were decreased when compared with those before treatment （P＜0.05）， and the scores were lower in the treatment group than in the control group （P＜0.05）. After treatment，the levels of PEF，FEV1，and FEV1/FVC in the two groups were increased when compared with those before treatment （P＜0.05），and the above indexes were higher in the treatment group than in the control group （P＜0.05）. After treatment， the scores for psychological status， concern for personal health， activity limitation， stimulus responses， and asthma symptoms in the AQLQ in the two groups were elevated when compared with those before treatment （P＜0.05）， and the above scores were higher in the treatment group than in the control group （P＜0.05）. During the treatment process， the incidence of adverse reactions was 2.50% （1/40） in the treatment group and 20.00% （8/40） in the control group， the difference being significant （P＜0.05）. Conclusion： Jingui Shenqi Pills combined with Budesonide Formoterol Powder Inhalation for patients with bronchial asthma with kidney yang deficiency type can improve their lung function and traditional Chinese medicine syndromes， reduce the incidence of adverse reactions，and enhance clinical efficacy and quality of life.